NEW YORK, Dec. 3 – Invitrogen, poised to post supercharged revenue and profit for the current fiscal year, said it will investigate running advertising in non-traditional scientific markets, and intends to revive slumping research and development spending by 2003.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.